ATE211141T1 - Diazepino-indole als phosphodiesterase iv inhibitoren - Google Patents

Diazepino-indole als phosphodiesterase iv inhibitoren

Info

Publication number
ATE211141T1
ATE211141T1 AT97919432T AT97919432T ATE211141T1 AT E211141 T1 ATE211141 T1 AT E211141T1 AT 97919432 T AT97919432 T AT 97919432T AT 97919432 T AT97919432 T AT 97919432T AT E211141 T1 ATE211141 T1 AT E211141T1
Authority
AT
Austria
Prior art keywords
nr2r3
diazepino
pcooh
ch2och2
nhr2
Prior art date
Application number
AT97919432T
Other languages
English (en)
Inventor
Yves Pascal
Henry Jacobelli
Alain Calvet
Adrian Payne
Svein G Dahl
Original Assignee
Jouveinal Inst Rech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jouveinal Inst Rech filed Critical Jouveinal Inst Rech
Application granted granted Critical
Publication of ATE211141T1 publication Critical patent/ATE211141T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Electric Double-Layer Capacitors Or The Like (AREA)
AT97919432T 1996-03-29 1997-03-27 Diazepino-indole als phosphodiesterase iv inhibitoren ATE211141T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9604013A FR2746800B1 (fr) 1996-03-29 1996-03-29 Diazepino-indoles inhibiteurs de phosphodiesterases 4
PCT/FR1997/000557 WO1997036905A1 (fr) 1996-03-29 1997-03-27 Diazepino-indoles inhibiteurs de phosphodiesterases 4

Publications (1)

Publication Number Publication Date
ATE211141T1 true ATE211141T1 (de) 2002-01-15

Family

ID=9490742

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97919432T ATE211141T1 (de) 1996-03-29 1997-03-27 Diazepino-indole als phosphodiesterase iv inhibitoren

Country Status (18)

Country Link
US (1) US5972927A (de)
EP (2) EP1132390A3 (de)
JP (1) JP2001510441A (de)
KR (1) KR19990022100A (de)
CN (1) CN1066149C (de)
AT (1) ATE211141T1 (de)
AU (1) AU735631B2 (de)
BR (1) BR9702180A (de)
CA (1) CA2220407A1 (de)
DE (1) DE69709272T2 (de)
DK (1) DK0828742T3 (de)
EA (2) EA002189B1 (de)
ES (1) ES2168627T3 (de)
FR (1) FR2746800B1 (de)
IL (1) IL122291A (de)
NZ (1) NZ329532A (de)
PT (1) PT828742E (de)
WO (1) WO1997036905A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2715683A1 (en) 1999-08-21 2001-03-01 Nycomed Gmbh Synergistic combination
MXPA02008627A (es) 2000-03-03 2003-02-24 Pfizer Prod Inc Derivados de eteres de pirazol como agentes antiinflamatorios/analgesicos.
EP1161950A1 (de) * 2000-06-09 2001-12-12 Warner-Lambert Company Verwendung von Diazepinoindolen zur Behandlung von chronisch obstruktiver Lungenkrankheiten
EP1161949A1 (de) * 2000-06-09 2001-12-12 Warner-Lambert Company Verwendung von diazepinoindolen zur behandlung von chronisch obstruktiver lungenkrankheiten
US6953774B2 (en) * 2000-08-11 2005-10-11 Applied Research Systems Ars Holding N.V. Methods of inducing ovulation
EP1188438A1 (de) * 2000-09-15 2002-03-20 Warner-Lambert Company Pharmazeutische Zusammensetzungen zur Vorbeugung oder Behandlung von mit IL-12 Überproduktion assozierten Erkrankungen
EP1199074A1 (de) * 2000-09-15 2002-04-24 Warner-Lambert Company Pharmazeutische Zusammensetzungen zur Vorbeugung oder Behandlung von mit IL-12 Überproduktion assozierten Erkrankungen
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
ES2335498T3 (es) 2003-03-10 2010-03-29 Nycomed Gmbh Nuevo proceso para la preparacion de reflumilast.
US7153824B2 (en) 2003-04-01 2006-12-26 Applied Research Systems Ars Holding N.V. Inhibitors of phosphodiesterases in infertility
EP1661886B1 (de) 2003-08-29 2016-08-10 Mitsui Chemicals Agro, Inc. Insektizid zur verwendung in der landwirtschaft bzw. im gartenbau und verfahren zu dessen anwendung
US8663694B2 (en) 2005-03-16 2014-03-04 Takeda Gmbh Taste masked dosage form containing roflumilast
EP2275095A3 (de) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenese durch modulation des Muscarinrezeptors
EP2258358A3 (de) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenese mit Acetylcholinesterasehemmer
EP1940389A2 (de) 2005-10-21 2008-07-09 Braincells, Inc. Modulation von neurogenese durch pde-hemmung
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
JP2009536667A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド ５ｈｔ受容体介在性の神経新生
EP2382975A3 (de) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenese mittels Angiotensin-Modulation
AU2007292848A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
KR20100014565A (ko) * 2007-04-11 2010-02-10 알콘 리서치, 리미티드 알레르기성 비염 및 알레르기성 결막염을 치료하기 위한 ｔｎｆａ의 억제제 및 항히스타민의 용도
US20090182035A1 (en) * 2007-04-11 2009-07-16 Alcon Research, Ltd. Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
CN102548536A (zh) * 2009-10-01 2012-07-04 爱尔康研究有限公司 奥洛他定组合物及其用途
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
CN117757730B (zh) * 2023-12-26 2024-06-07 浙江普罗亭健康科技有限公司 一种人心脏组织消化专用试剂盒及消化方法、检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4840947A (en) * 1986-10-14 1989-06-20 Hoechst-Roussel Pharmaceuticals, Inc. Antiinflammatory and analgesic piperidin-4-yl-tetracyclic benzodiazepines and use thereas
FR2652352A1 (fr) * 1989-09-28 1991-03-29 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique.
FR2725719B1 (fr) * 1994-10-14 1996-12-06 Jouveinal Inst Rech Diazepino-indoles inhibiteurs de phosphodiesterases iv

Also Published As

Publication number Publication date
BR9702180A (pt) 1999-12-28
EA199900624A1 (ru) 2000-06-26
EP0828742A1 (de) 1998-03-18
AU735631B2 (en) 2001-07-12
HK1018051A1 (en) 1999-12-10
CN1189832A (zh) 1998-08-05
EP1132390A3 (de) 2001-10-10
PT828742E (pt) 2002-06-28
NZ329532A (en) 2000-03-27
IL122291A (en) 2000-12-06
DE69709272T2 (de) 2002-08-08
EP0828742B1 (de) 2001-12-19
EP1132390A2 (de) 2001-09-12
KR19990022100A (ko) 1999-03-25
EA002189B1 (ru) 2002-02-28
DK0828742T3 (da) 2002-04-15
DE69709272D1 (de) 2002-01-31
FR2746800B1 (fr) 1998-06-05
CA2220407A1 (fr) 1997-10-09
EA001593B1 (ru) 2001-06-25
IL122291A0 (en) 1998-04-05
AU2391397A (en) 1997-10-22
ES2168627T3 (es) 2002-06-16
US5972927A (en) 1999-10-26
FR2746800A1 (fr) 1997-10-03
WO1997036905A1 (fr) 1997-10-09
CN1066149C (zh) 2001-05-23
EA199700346A1 (ru) 1998-10-29
JP2001510441A (ja) 2001-07-31

Similar Documents

Publication Publication Date Title
ATE211141T1 (de) Diazepino-indole als phosphodiesterase iv inhibitoren
DE69129009D1 (de) Indole Derivate als Serotonin-Antagonisten
PT756594E (pt) Preparacao de oxadiazinas artropodicidas
DE122011100040I1 (de) Zusammensetzung, verfahren und instrument zur potenzierung der antitumoraktivitat und zur behandlungvon tumoren.
ATE237612T1 (de) Benzofuranderivate
DE68924556D1 (de) N-(N-(Tetrahydropyrido[2,3-d]pyrimidinylmethyl)-aminomethylbenzoyl)glutaminsäure-Derivate.
DE59006544D1 (de) 1,7-anellierte 1H-Indol-2-carbonsäure-N-(1,4-benzodiazepin-3-yl)amide.
DK640889A (da) Fenylderivater med antidiabetisk, isaer hypoglykaemisk virkning
DK0591058T3 (da) Ellipticinderivater med antitumoraktivitet
DK0428313T3 (da) Pyrimidonderivater samt analoge til behandling af astma og visse hudlidelser
ES2183036T3 (es) 2,2' - disustituidos-ferrocenos 2,2`-disustituidos y 1-fosfino-ferrocenos 1`,2-disustituidos, procedimiento para su preparacion, su utilizacion, asi como complejos de metales de transicion que los contienen,.
PL245702A1 (en) Method of obtaining new heterocyclic compounds
SE8203877D0 (sv) Aminosulfonylbensoesyraderivat
ES2076959T3 (es) Nuevos derivados de amino acidos.
DE69423055D1 (de) Indol Derivate als Glutamat Antagonisten
GB2001309A (en) alpha -Halomethyl beta -(3-indolyl) amino acids and derivatives
DE3675431D1 (de) 1,3-oxathianderivate.
DE69222818D1 (de) Kondensierte Naphthyridinderivate
ATE96026T1 (de) Verwendung heterozyklischer amide zur verhinderung der tumormetastasierung.
ES2192342T3 (es) 2-(2,6-dioxo-3-fluoropiperidin-3-il)-isoindolinas sustituidas y su uso para reducir los niveles de tnfalfa.
GB2001627A (en) alpha -Vinyl and ethynyl amino acid derivatives

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee